The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).

scientific article published in August 2000

The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/HEART.84.2.142
P932PMC publication ID1760917
P698PubMed publication ID10908248
P5875ResearchGate publication ID275392646

P2093author name stringYusuf S
Gibbons RJ
Christian TF
Burns R
Roberts RS
Chareonthaitawee P
P2860cites workPredictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I InvestigatorsQ34320363
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hourQ34398044
Experimental infarct size as a function of the amount of myocardium at riskQ36058431
Discrepancies between the effects of coronary reperfusion on survival and left ventricular functionQ38352395
Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?Q40819790
Determinants of infarct size in reperfusion therapy for acute myocardial infarctionQ41113237
The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patientsQ41455459
The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flowQ41640497
Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrileQ43520793
Effect of infarct location on myocardial salvage assessed by technetium-99m isonitrileQ44366558
Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction TrialQ47182817
Effect of coronary occlusion site on ischaemic bed size and collateral blood flow in dogsQ47276092
Relation between symptom duration before thrombolytic therapy and final myocardial infarct sizeQ47341469
Prehospital thrombolysis: beneficial effects of very early treatment on infarct size and left ventricular functionQ47385813
Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: identification of myocardial stunning and hyperkinesiaQ47438842
Time to therapy and salvage in myocardial infarctionQ47762375
Repeatability of estimates of left-ventricular volume from blood-pool counts: concise communication.Q52702233
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.Q53367479
Myocardial infarction in the conscious dog: three-dimensional mapping of infarct, collateral flow and region at riskQ66940511
The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized TrialQ68124770
In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi)Q68441700
Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase TrialQ69615485
Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionQ70303248
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trialQ70331348
Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trialQ70398132
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I InvestigatorsQ71571187
Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibiQ72523279
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention TrialQ72889394
A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communicationQ72926941
Factors influencing myocardial salvage with primary angioplastyQ74011427
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarctionQ93523682
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
collaborationQ1145523
thrombolysisQ1931577
P304page(s)142-148
P577publication date2000-08-01
P1433published inHeartQ856338
P1476titleThe impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).
P478volume84

Reverse relations

cites work (P2860)
Q222419192013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Q35378823A new performance indicator for acute myocardial infarction
Q47963971Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
Q64081787Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury
Q53363030Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.
Q93630356Commentary
Q24809775Differences in access to coronary care unit among patients with acute myocardial infarction in Rome: old, ill, and poor people hold the burden of inefficiency
Q38263336How frequent is the fifth arch artery?
Q35580444Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction
Q37007028Patterns of ST segment resolution after guidewire passage and thrombus aspiration in primary percutaneous coronary intervention (PPCI) for acute myocardial infarction
Q38603311Persistent fifth aortic arch: the "great pretender" in clinical practice
Q36017226Pre-hospital delay in patients with first time myocardial infarction: an observational study in a northern Swedish population
Q90728820Prevalence and Predictors of Delay in Seeking Emergency Care in Patients Who Call 9-1-1 for Chest Pain
Q47174579Role of infarct size in explaining the higher mortality in older patients with acute myocardial infarction
Q81510641Survival of patients receiving fibrinolytic therapy for acute ST-segment elevation myocardial infarction in a developing country - patient characteristics and predictors of mortality
Q47393668Tc-99m sestamibi infarct size as a surrogate endpoint
Q41033857The contribution of symptom incongruence to prehospital delay for acute myocardial infarction symptoms among Jordanian patients
Q38199360Therapy in ST-elevation myocardial infarction: reperfusion strategies, pharmacology and stent selection.
Q73852962[Impact of a public-directed media campaign on emergency call to a mobile intensive care units center for acute chest pain]

Search more.